These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 12489805)
1. APP, Notch, and presenilin: molecular pieces in the puzzle of Alzheimer's disease. Wolfe MS Int Immunopharmacol; 2002 Dec; 2(13-14):1919-29. PubMed ID: 12489805 [TBL] [Abstract][Full Text] [Related]
2. gamma-Secretase inhibitors as molecular probes of presenilin function. Wolfe MS J Mol Neurosci; 2001 Oct; 17(2):199-204. PubMed ID: 11816793 [TBL] [Abstract][Full Text] [Related]
3. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease. Steiner H; Capell A; Leimer U; Haass C Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281 [TBL] [Abstract][Full Text] [Related]
4. Secretase as a target for Alzheimer's disease. Wolfe MS Curr Top Med Chem; 2002 Apr; 2(4):371-83. PubMed ID: 11966461 [TBL] [Abstract][Full Text] [Related]
5. BACE1: the beta-secretase enzyme in Alzheimer's disease. Vassar R J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696 [TBL] [Abstract][Full Text] [Related]
6. Role of presenilin in gamma-secretase cleavage of amyloid precursor protein. Xia W Exp Gerontol; 2000 Jul; 35(4):453-60. PubMed ID: 10959033 [TBL] [Abstract][Full Text] [Related]
7. A portrait of Alzheimer secretases--new features and familiar faces. Esler WP; Wolfe MS Science; 2001 Aug; 293(5534):1449-54. PubMed ID: 11520976 [TBL] [Abstract][Full Text] [Related]
8. Failure of the interaction between presenilin 1 and the substrate of gamma-secretase to produce Abeta in insect cells. Pitsi D; Kienlen-Campard P; Octave JN J Neurochem; 2002 Oct; 83(2):390-9. PubMed ID: 12423249 [TBL] [Abstract][Full Text] [Related]
9. The presenilins in Alzheimer's disease--proteolysis holds the key. Haass C; De Strooper B Science; 1999 Oct; 286(5441):916-9. PubMed ID: 10542139 [TBL] [Abstract][Full Text] [Related]
10. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Selkoe DJ Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11039-41. PubMed ID: 11572965 [TBL] [Abstract][Full Text] [Related]
11. The inhibition of gamma-secretase as a therapeutic approach to Alzheimer's disease. Tomita T; Iwatsubo T Drug News Perspect; 2004 Jun; 17(5):321-5. PubMed ID: 15334182 [TBL] [Abstract][Full Text] [Related]
12. Nicastrin is required for assembly of presenilin/gamma-secretase complexes to mediate Notch signaling and for processing and trafficking of beta-amyloid precursor protein in mammals. Li T; Ma G; Cai H; Price DL; Wong PC J Neurosci; 2003 Apr; 23(8):3272-7. PubMed ID: 12716934 [TBL] [Abstract][Full Text] [Related]
13. Selecting cells with different Alzheimer's disease gamma-secretase activity using FACS. Differential effect on presenilin exon 9 gamma- and epsilon-cleavage. Sernee MF; Evin G; Culvenor JG; Villadangos JA; Beyreuther K; Masters CL; Cappai R Eur J Biochem; 2003 Feb; 270(3):495-506. PubMed ID: 12542699 [TBL] [Abstract][Full Text] [Related]
14. The beta-secretase, BACE: a prime drug target for Alzheimer's disease. Vassar R J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789 [TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. Evin G; Zhu A; Holsinger RM; Masters CL; Li QX J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315 [TBL] [Abstract][Full Text] [Related]
17. [The mechanism of A beta production and its inhibition as a therapeutic strategy for the prevention of Alzheimer's disease]. Iwatsubo T Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):30P-33P. PubMed ID: 12491772 [TBL] [Abstract][Full Text] [Related]
18. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Li YM; Xu M; Lai MT; Huang Q; Castro JL; DiMuzio-Mower J; Harrison T; Lellis C; Nadin A; Neduvelil JG; Register RB; Sardana MK; Shearman MS; Smith AL; Shi XP; Yin KC; Shafer JA; Gardell SJ Nature; 2000 Jun; 405(6787):689-94. PubMed ID: 10864326 [TBL] [Abstract][Full Text] [Related]
19. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment. Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373 [TBL] [Abstract][Full Text] [Related]
20. [Beta-amyloid protein: recent progress in basic research and therapeutic approaches]. Iwatsubo T Rinsho Shinkeigaku; 2001 Dec; 41(12):1198-200. PubMed ID: 12235837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]